31 reports

SMA AFFECTS APPROXIMATELY ONE IN EVERY ##, ## INFANTS, WHILE ONE IN ## PEOPLE IS A CARRIER FOR THE DISORDER.

  • Blood Disease
  • Cancer
  • Clinical Trial
  • Type 2 Diabetes
  • AutoGenomics, Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

## ## ## ## ## United Kingdom ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## France Source: GlobalData' s Pharma Intelligence Center Clinical

  • Blood Disease
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • OBESITY - PIPELINE BY OMEROS CORP, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017 (CONTD..7), H2 2017

IT WAS ALSO UNDER DEVELOPMENT FOR MOOD DISORDER AND BIPOLAR DISORDER.

  • Blood Disease
  • Diabetes
  • Obesity
  • Type 2 Diabetes
  • Omeros Corporation

Its products are indicated for the treatment of diseases such as Alzheimer' s disease, depression, Parkinson' s disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, epilepsy and Huntington' s disease, among others.

  • Blood Disease
  • Therapy
  • Type 2 Diabetes
  • United States
  • Shire plc

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Blood Disease
  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • Bayer AG

Pfizer India offers medicines to treat Alzheimer' s disease, autism, bipolar disorder, depression, Parkinson' s disease, schizophrenia and others.

  • Blood Disease
  • Therapy
  • Type 2 Diabetes
  • United States
  • Pfizer Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Anti-Infective
  • Blood Disease
  • Clinical Trial
  • Pharmaceutical
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • Drug Development
  • Therapy
  • World
  • GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY DISEASE, 2014-2021, (USD MILLION)

TPE is regarded as one of the most useful treatment options for many renal disorders.

  • Blood Disease
  • Type 2 Diabetes
  • North America
  • United States
  • World

Its preclinical product candidates are intended for treatment of bleeding disorders, alternative pathway disorders, central nervous system disorders, metabolic, oncologic, musculoskeletal and other disorders.

  • Blood Disease
  • Cardiovascular Disease
  • Chronic Disease
  • Type 2 Diabetes
  • Esperion Therapeutics, Inc.
  • 5. All the trials included are unique trials.

A Double Blind, Randomized, Placebo Controlled Trial Maternal Hypotension During Elective Caesarean Delivery under Various Spinal Anaesthesia Regimens GDCT## ACTRN##, Cardiovascular Arrhythmias, Emesis (Vomiting), Hypotension, Nausea, Unspecified Respiratory Disorders Ongo

  • Blood Disease
  • Pharmaceutical
  • Type 2 Diabetes
  • World
  • Product Initiative

LUNDBECK AS Alzheimer' s disease, depression, Parkinson' s disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, epilepsy and Huntington' s disease among others.

  • Blood Disease
  • Chronic Disease
  • Type 2 Diabetes
  • Product Initiative
  • HanAll Biopharma Co., Ltd.
  • Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) - Dormant Projects

Neurim mainly specializes on age-related disorders.

  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative
  • DiaMedica Inc.

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Blood Disease
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative

Hoffmann-La Roche Ltd AstraZeneca Plc Acorda Therapeutics Inc Johnson & Johnson Phase IV Phase III/ IV Phase III Phase II/ III Phase II Phase I/ II Phase I TOTAL ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Blood Disease
  • Pharmaceutical
  • Stroke
  • Type 2 Diabetes
  • World

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Blood Disease
  • Cell Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • ASTELLAS: LATE STAGE PRODUCT PIPELINE

TWO: INTRODUCTION ## TABLE ##- ## TOP PHARMACEUTICAL COMPANIES, ##-## BY 2015 PHARMACEUTICAL SALES ($ MILLIONS) Position ## ## Company Pfizer Novartis Pharma Sales 2015 $##, ## ##, ## TWO: INTRODUCTION ## TABLE ##- ## TOP PHARMACEUTICAL COMPANIES, ##-## BY 2015 P

  • Blood Disease
  • Type 2 Diabetes
  • Company
  • Demand
  • Merck & Co., Inc.

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale metaanalysis.

  • Blood Disease
  • Diabetes
  • Insulin
  • Type 2 Diabetes
  • Deals & Alliance

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Blood Disease
  • Diabetes
  • Type 2 Diabetes
  • United States
  • Company

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Blood Disease
  • Chronic Disease
  • Genitourinary System Disease
  • Type 2 Diabetes
  • Product Initiative

Ltd. registered a Phase I dose block-randomized, double-blind, placebo-controlled, single dose, dose-escalation study to investigate the safety, tolerance, pharmacokinetics and pharmacodynamics of tolvaptan in healthy Korean male subjects bipolar disorder.

  • Blood Disease
  • Diabetes
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • OBESITY - PIPELINE BY OMEROS CORPORATION, H2 2016
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016 (CONTD..7)

Reviva Pharma' s product RP## is also been developing for Parkinson' s psychosis (PDP), attention deficit hyperactivity disorder (ADD/ ADHD), bipolar disorder, major depressive disorder (MDD), Alzheimer' s psychosis/ agitation (ADP), and auti

  • Blood Disease
  • Chronic Disease
  • Type 2 Diabetes
  • Company
  • Product Initiative

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Blood Disease
  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • Astellas Pharma Inc. - Pipeline by Indication, 2016

It is also used in adults for adjunctive therapy to antidepressants in major depressive disorder; acute depressive episodes in bipolar disorder; acute manic or mixed episodes in bipolar I disorder, as either monotherapy or adjunct therapy to lith

  • Blood Disease
  • Cell Therapy
  • Research And Development
  • Type 2 Diabetes
  • Astellas Pharma Inc.
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Blood Disease
  • Therapy
  • Type 2 Diabetes
  • World
  • Product Initiative

Earlier, GlaxoSmithKline (GSK) was engaged in the development of GSK## for the treatment of bipolar disorder and neuropathic pain.

  • Blood Disease
  • Monoclonal Antibody
  • Therapy
  • Type 2 Diabetes
  • Biogen Idec Inc.
  • IMC-GP75

TRPV## (transient receptor potential cation channel, subfamily V, member ##) is a polymodal nociceptor whose expression is upregulated in several painful disorders.

  • Blood Disease
  • Research And Development
  • Type 2 Diabetes
  • United States
  • Eli Lilly & Co.
  • CHRONIC PAIN

It is also used in adults for adjunctive therapy to antidepressants in major depressive disorder; acute depressive episodes in bipolar disorder; acute manic or mixed episodes in bipolar I disorder, as either monotherapy or adjunct therapy to lith

  • Blood Disease
  • Cancer
  • Type 2 Diabetes
  • United States
  • AstraZeneca PLC

It covers the methods of treating diseases mediated by PDE##, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

  • Blood Disease
  • Monoclonal Antibody
  • Therapy
  • Type 2 Diabetes
  • Amgen Inc.
  • LEUKEMIA, RELAPSED ACUTE MYELOID LEUKEMIA

Key Therapeutic Areas Cardiovascular Central Nervous System Dermatology Ear Nose Throat Disorders Gastrointestinal Genetic Disorders Genito Urinary System And Sex Hormones Hematological Disorders Immunology Infectious Disease Metabolic Disorders Musculoskeletal

  • Blood Disease
  • Cancer
  • Monoclonal Antibody
  • Type 2 Diabetes
  • United States